Utilisation study of antipyretic drugs in paediatric patients

Authors

  • Arina Dery Puspitasari Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia & Universitas Airlangga Hospital, Surabaya, Indonesia
  • Anita Nur Azizah Bachelor Programme Study of Pharmacy, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia https://orcid.org/0009-0002-0357-3528
  • Wenny Putri Nilamsari Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
  • Robby Nurhariansyah Universitas Airlangga Hospital, Surabaya, Indonesia https://orcid.org/0009-0002-8905-4357
  • Ika Nursetyo Palupi Universitas Airlangga Hospital, Surabaya, Indonesia

DOI:

https://doi.org/10.46542/pe.2024.243.234239

Keywords:

Antipyretic, Fever, Medicine, Metamizole, Paediatric, Paracetamol

Abstract

Background: Fevers are common in children with underlying diseases, so antipyretics are often used. However, no specific guidelines exist for the use of antipyretics in children.

Objective: This study aimed to determine the profile of antipyretics used by paediatric inpatients at Universitas Airlangga Hospital and to identify possible side effects and interactions associated with antipyretics use.

Method: This observational study was conducted from March to June 2023. Convenience sampling was used to collect retrospective data from patients’ medical records, which were then analysed descriptively.

Result: A total of 87 paediatric patients met the inclusion criteria. All paediatric patients received intravenous metamizole as an antipyretic treatment (100.0%), with 3 x 8 - 20 mg/kgBW as needed (55.2%) being the most used dosage regimen. Metamizole as monotherapy was the most widely used pattern (80.5%), and it showed the shortest mean duration of therapy. Paracetamol was only used in switching (11.5%) and alternating (8.1%) patterns. Abdominal pain was the most actual suspected side effect of metamizole (3.4%). No potential drug interactions associated with antipyretics were found.

Conclusion: In general, intravenous metamizole effectively reduced fever in most paediatric patients at Universitas Airlangga Hospital.

References

Barbi, E., Marzuillo, P., Neri, E., Naviglio, S., & Krauss, B. S. (2017). Fever in children: Pearls and pitfalls. Children, 4(81), 1–19. http://dx.doi.org/10.3390/children4090081

de Leeuw, T. G., Dirckx, M., Candel, A. G., Scoones, G. P., Huygen, F. J. P. M., & de Wildt, S. N. (2017). The use of dipyrone (metamizol) as an analgesic in children: What is the evidence? A review. Pediatric Anesthesia, 27(12), 1193–1201. https://dx.doi.org/10.1111/pan.13257

El-Radhi, A. S., Carroll, J., Klein, N., & Walsh, A., (2018). Management of fever (antipyretics). In A. S. El-Radhi (Eds.), Clinical manual of fever in children (2nd ed., pp. 225–252). Springer. https://doi.org/10.1007/978-3-319-92336-9_10

El-Radhi, A. S., Carroll, J., Klein, N., Hassan, M. K., Al-Naddawi, M. N., Kabra, S. K., & Olofsson O. E. E. G., (2018). Fever in common infectious diseases. In A. S. El-Radhi (Eds.), Clinical manual of fever in children (2nd ed., pp. 85–140). Springer. https://doi.org/10.1007/978-3-540-78598-95

Ince, I., Aksoy, M., Ahiskalioglu, A., Comez, M., Dostbil, A., Celik, M., Yilmaz, I., Mammadov, R., Ozgermen, B. B., & Altuner, D. (2015). A comparative investigation of the analgesic effects of metamizole and paracetamol in rats. Journal of Investigative Surgery, 28(3), 173–180. https://doi.org/10.3109/08941939.2014.998798

Jaillon, S., Berthenet, K., & Garlanda, C. (2019). Sexual dimorphism in innate immunity. Clinical Reviews in Allergy & Immunology, 56, 308–321. https://doi.org/10.1007/s12016-017-8648-x

Kloc, M., Ghobrial, R. M., Kuchar, E., Lewicki, S., & Kubiak, J. Z. (2020). Development of child immunity in the context of the COVID-19 pandemic. Clinical Immunology, 217, 108510. https://doi.org/10.1016/j.clim.2020.108510

Kuo, N., Su, N. Y., Hou, S. K., & Kang, Y. N. (2022). Effects of acetaminophen and ibuprofen monotherapy in febrile children: A meta-analysis of randomised controlled trials. Archives of Medical Science, 18(4), 965–981. https://doi.org/10.5114/aoms/140875

National Institute of Health and Care Excellence. (2013). Feverish illness in children: Assessment and initial management in children younger than 5 years. https://www.nice.org.uk/guidance/cg160

Norcahyanti, I., Rosyidah, M., Jaelani, A. K., & Pratama, A. N. (2021). IAI CONFERENCE: Antibiotic use on paediatric inpatients in a public hospital in Bangil, Indonesia. Pharmacy Education, 21(2), 163–167. https://doi.org/10.46542/pe.2021.212.163167

Simon, A. K., Hollander, G. A., & McMichael, A. (2015). Evolution of the immune system in humans from infancy to old age. Proceedings of the Royal Society B, 282, 20143085. http://dx.doi.org/10.1098/rspb.2014.3085

Tasker, R. C., McClure, R. J., & Acerini, C. L. (Eds.). (2013). Oxford handbook of paediatrics (2nd ed.). Oxford University Press.

World Health Organization. (2013). Pocket book of hospital care for children (2nd ed.). World Health Organization.

World Health Organisation. (2023). Reported potential side effects. https://www.vigiaccess.org/

Zahn, J., Eberl, S., Rödle, W., Rascher, W., Neubert, A., & Toni, I. (2021). Metamizole use in children: Analysis of drug utilisation and adverse drug reactions at a German university hospital between 2015 and 2020. Paediatric Drugs, 24(1), 45–56. https://doi.org/10.1007/s40272-021-00481-z

Downloads

Published

01-05-2024

How to Cite

Puspitasari, A. D., Azizah, A. N., Nilamsari, W. P., Nurhariansyah, R., & Palupi, I. N. (2024). Utilisation study of antipyretic drugs in paediatric patients. Pharmacy Education, 24(3), p. 234–239. https://doi.org/10.46542/pe.2024.243.234239